Breast Cancer

The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.

Latest News

T-DXd New Standard of Care Following ET in HER2-Low, -Ultralow HR+ Metastatic Breast Cancer
T-DXd New Standard of Care Following ET in HER2-Low, -Ultralow HR+ Metastatic Breast Cancer

June 3rd 2024

Data presented at ASCO 2024 show fam-trastuzumab deruxtecan-nxki (T-DXd) delayed cancer growth in patients with hormone receptor-positive (HR+), HER2-low or -ultralow disease that progressed following endocrine therapy (ET).

breast cancer NATALEE ASCO 2024
NATALEE Data Show Ribociclib Reduces Risk of Recurrence for High-Risk Node-Negative Early Breast Cancer

June 1st 2024

breast cancer treatment/Image Credits: © ChenPG - adobe.stock.com
FDA Grants Inavolisib Priority Review for Treatment of PIK3CA-Mutated Breast Cancer

May 31st 2024

Breast cancer awareness -- Image credit: Konstantin Yuganov | stock.adobe.com
Breast Cancer Endocrine Therapy Nonpersistence, Nonadherence Associated With Socioeconomic and Behavioral Factors

May 28th 2024

breast cancer treatment
FDA Grants Breakthrough Therapy Designation to Inavolisib for PIK3CA-Mutated Breast Cancer

May 21st 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.